Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease

Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of thyroid remnant ablation with radioactive iodine (RAI) in low risk patients with well differentiated thyroid cancer (DTC). We studied the safety and efficacy of rhTSH preparation for RAI treatment of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfson, Robert M., Rachinsky, Irina, Morrison, Deric, Driedger, Al, Spaic, Tamara, Van Uum, Stan H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763009/
https://www.ncbi.nlm.nih.gov/pubmed/26977148
http://dx.doi.org/10.1155/2016/6496750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763009/
https://www.ncbi.nlm.nih.gov/pubmed/26977148
http://dx.doi.org/10.1155/2016/6496750

Ejemplares similares